Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Science Advances April 1, 2026 Paula Berman, Janka Höfer, Herschel Mehlman et al. 1 citation
A biosynthetic pathway for dimethyltryptamine (DMT) was reconstructed in a plant assay, along with the full pathways of five natural psychedelics: psilocin, psilocybin, DMT, bufotenin, and 5-methoxy-DMT. Halogenated analogs of these molecules, which do not occur naturally and may have therapeutic potential for psychiatric conditions, were also engineered. By blending catalytic functions from different organisms and using rational protein design to create mutant enzymes, the production of indolethylamine components in plants became substantially more efficient. This platform enables concurrent biosynthesis and diversification of psychoactive indolethylamines.